WHO Confirms the Quality of Vaccines by FSUE SPbSRIVS FMBA of Russia

The current influenza strain antigen for the 2019-2020 vaccine season produced by FSUE SPbSRIVS FMBA of Russia promptly for the WHO system (GISRS) was used by the key laboratory (NIBSC) for manufacturing the standard antigen and received catalog number 19/154. This indicates a high level of quality of SPbSRIVS products that meet not only the
Tagged under: , ,

SPbSRIVS FMBA of Russia participated in the St. Petersburg International Economic Forum 2019

The first day of the SPIEF 2019 was marked by a Russian-Nicaraguan meeting at the government level. The parties signed a Memorandum of Cooperation in various fields between the Russian Federation and the Republic of Nicaragua. The signing of the Memorandum was preceded by a rich history of interaction between the countries. Russia and Nicaragua

Production of Russian vaccines in Latin America has been launched!

Institute MECHNIKOV, created as part of the Russian and Nicaraguan project in Managua, began production of commercial batches of influenza vaccine. April 10. Managua. Institute MECHNIKOV has launched the production of a commercial vaccine batches in Managua (Nicaragua). The launch of the production lines was attended by the advisor for investments of the Government of
Tagged under: , , , , , , , , ,

The Latin American Biotechnology Institute MECHNIKOV is being inspected for receiving GMP certification

From 14 to 18 January 2019, the final GMP audit of the Latin American Institute of Biotechnology MECHNIKOV has been started by the Cuban National Regulatory Authority CECMED. Let us recall that that the final audit was preceded by intensive work carried out by specialists from MECHNIKOV Institute in December. Thus, the MFT (media fill
Tagged under:

SPbSRIVS takes part in the 60th Damascus International Fair in Syria

Sep. 6 – 15, under the patronage of President Bashar al-Assad, the 60th edition of Damascus International Fair was held. Among other participants, the Russian delegation was represented by the director of St. Petersburg Scientific Research Institute of Vaccines and Serums Victor Trukhin and the director’s advisor Sergey Arakelov. During the exhibition, Vladimir Uiba, the director of
Tagged under: , ,

SPbSRIVS received official GMP certification from the Directorate of Sanitary Control of Iran

In June 2018, as part of the strengthening of potential export, the St. Petersburg Scientific Research Institute of Vaccines and Serums has successfully passed the certification audit for compliance with antigen production quality for influenza vaccines. Food and Drug Administration of the Islamic Republic of Iran issued the certificate in August of this year. It
Tagged under: , , , , ,

VTB Bank will provide SPbSRIVS a loan totalling more than $ 12 500 000 for the production of vaccines

VTB Bank will provide the Federal state unitary enterprise “Saint-Petersburg research Institute of vaccines and sera and enterprise and Biopharmaceutical Plant under Federal Medical Biological Agency of Russia” a loan totalling more than $ 12 500 000 for a period of 5 years. The loan agreement was signed in the framework of previously established credit limit for
Technical

The Technical Committee opens new horizons

April, 11, Latin American institute of biotechnology MECHNIKOV received honored guests from the Ministry of Health of Russia, Nicaraguan Institute of the Social Security (INSS), Federal medical-biological agency of Russia, CECMED and WHO/PAHO, who united in Managua to participate in Russian-Nicaraguan Technical Advisory Committee. This time meeting of the Technical Committee was highlighted by the
Tagged under: , , , , , ,
cooperation

SPbSRIVS develops cooperation with Chile

To continue and to expand the cooperation between Russia and Chile representatives of Institute of Public Health of Chile (ISP) visited vaccine production site in Krasnoe Selo. During the second visit to Russia Dr. Pablo Ortiz Diaz, Chief of Administration and Finances of ISP and Dr. Alejandro Salinas, Chief of department of International Relations and